Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
Shandong Cancer Hospital and Institute
Shandong Cancer Hospital and Institute
Eli Lilly and Company
Zhujiang Hospital
University Hospital, Gasthuisberg
City of Hope Medical Center
University of Miami
University of Utah
University of Alabama at Birmingham
M.D. Anderson Cancer Center
University of New Mexico